» Articles » PMID: 29175520

Alzheimer's Disease-associated Ubiquitin Mutant Ubb: Properties of the Carboxy-terminal Domain and Its Influence on Biomolecular Interactions

Overview
Publisher Elsevier
Date 2017 Nov 28
PMID 29175520
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Ubb, a ubiquitin (Ub) mutant protein originating from misreading of the Ub B gene, is found accumulated in brain tissues of Alzheimer's disease patients. The mutant attracts strong interest due to its possible participation in the molecular events leading to neurodegeneration. Ubb is composed of the globular domain of Ub, linked to a 19-residue C-terminal peptide. Based on NMR relaxation and solvent accessibility measurements we obtained new insight into the molecular properties of Ubb. We further determined the thermal stability of Ubb in the monomeric form, and in Lys48- and Lys63-linked dimers. Finally, we explored the influence of the C-terminal fragment on the interactions of Ubb with an isolated UBA2 domain and with membrane mimics. Our data indicate that the C-terminal fragment of Ubb is overall highly flexible, except for a short stretch which appears less solvent-exposed. While influencing the hydrodynamic properties of the globular domain, the fragment does not establish long-lived interactions with the globular domain. It results that the structure and stability of Ub are minimally perturbed by the peptide extension. However, binding to UBA2 and to membrane mimics are both affected, exemplifying possible changes in biomolecular recognition experienced by the disease-associated Ubb compared to the wild-type protein.

Citing Articles

The Dose-Dependent Pleiotropic Effects of the UBB Ubiquitin Mutant.

Banasiak K, Szulc N, Pokrzywa W Front Mol Biosci. 2021; 8:650730.

PMID: 33842548 PMC: 8032880. DOI: 10.3389/fmolb.2021.650730.


Mendelian randomization integrating GWAS and mQTL data identified novel pleiotropic DNA methylation loci for neuropathology of Alzheimer's disease.

Liu D, Wang Y, Jing H, Meng Q, Yang J Neurobiol Aging. 2020; 97:18-27.

PMID: 33120085 PMC: 7736197. DOI: 10.1016/j.neurobiolaging.2020.09.019.


Screening and Identification of Potential Peripheral Blood Biomarkers for Alzheimer's Disease Based on Bioinformatics Analysis.

Wang X, Wang L Med Sci Monit. 2020; 26:e924263.

PMID: 32812532 PMC: 7453750. DOI: 10.12659/MSM.924263.


Semisynthetic Modification of Tau Protein with Di-Ubiquitin Chains for Aggregation Studies.

Munari F, Barracchia C, Parolini F, Tira R, Bubacco L, Assfalg M Int J Mol Sci. 2020; 21(12).

PMID: 32575755 PMC: 7352214. DOI: 10.3390/ijms21124400.


A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Pall. On the Treatment of Alzheimer's Disease.

Zeng Q, Li L, Jin Y, Chen Z, Duan L, Cao M Evid Based Complement Alternat Med. 2019; 2019:8706589.

PMID: 31827565 PMC: 6885190. DOI: 10.1155/2019/8706589.